Clinical Trials Logo

Resectable Bladder Cancer clinical trials

View clinical trials related to Resectable Bladder Cancer.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02053220 Completed - Clinical trials for Resectable Non-small Cell Lung Cancer

Mechanism of Action Trial of ColoAd1

MOA
Start date: June 2013
Phase: Phase 1
Study type: Interventional

To assess the pattern of ColoAd1 viral delivery and viral expression within colon tumour tissue when administered by intra-tumoural injection or within colon, non-small cell lung, bladder and renal cell tumour tissues following ColoAd1 administration by intravenous infusion.